Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1999
11/02/1999US5977073 Adjustment of concentration of glutathion in mammals
11/02/1999US5977072 Polypeptide
11/02/1999US5977071 Complexes; antidiabetic agent
11/02/1999US5977070 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
11/02/1999US5977069 Mixture of growth hormone and asparagine as stabilizer
11/02/1999US5977068 Parenteral administering
11/02/1999US5977067 Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them
11/02/1999US5977066 Oral administering mixture containing glycerides and reaction product of hydrogenated castor oil and ethylene glycol
11/02/1999US5977065 Bacterial nitroreductase for the reduction of CB1954 and analogues thereof to a cytotoxic form
11/02/1999US5977064 Cyclic tetrapeptide as anticoagulant
11/02/1999US5977063 Alkylated hexapeptides
11/02/1999US5977062 Active against antibiotic resistant bacteria
11/02/1999US5977057 Administering tissue factor pathway inhbibitor
11/02/1999US5977056 Treatment of thrombotic events
11/02/1999US5976879 Antisense oligonucleotides which combat aberrant splicing and methods of using the same
11/02/1999US5976877 Proteins produced by human lymphocytes DNA sequence encoding these proteins and their pharmaceutical and biological uses
11/02/1999US5976874 These plasmids will spread quickly through the antibiotic-resistant population of bacterial cells, thereby making the cells susceptible to antibiotic therapy.
11/02/1999US5976872 Brain transcription factors, nucleic acids encoding same and uses thereof
11/02/1999US5976858 (s)-(e)-3-(4-morpholine-carbonylleucyl)amino-5-phenyl-1-phenyl sulfonyl-1-pentene and others; antiarthritis/antitumor/ antiinflammatory/antimetastasis agents; treatment of muscular dystrophy, malaria, alzheimer's and autoimmune diseases
11/02/1999US5976854 Calcium independent cytosolic phospholipase A2 /B enzymes
11/02/1999US5976849 Human E3 ubiquitin protein ligase
11/02/1999US5976841 Proteins having fibrinolytic and coagulation--inhibiting properties
11/02/1999US5976839 Plasmid for production of fusion protein of immunogen and peptide carrier from an escherichia coli membrane protein; enhanced immune response in host regardless of whether protein is administered parenterally, orally, or enterally
11/02/1999US5976838 Secreted proteins and polynucleotides encoding them
11/02/1999US5976837 Secreted proteins and polynucleotides encoding them
11/02/1999US5976835 Nucleic acids encoding receptor recognition factor Stat1α and Stat1β, and methods of use thereof
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976831 Therapeutic compounds, and more particularly to soluble and membrane-bound forms of a low-affinity receptor for human immunoglobulin g, nucleic acids encoding the same. diagnostic uses of such receptors.
11/02/1999US5976815 Screening drugs/ligands of activin receptor-like kinase 7 receptor by transfecting host cell with nucleic acid encoding receptor protein, contacting cell with drug/ligand, evaluating effect on kinase activity
11/02/1999US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
11/02/1999US5976808 Assays for identifying agents which affect regulators of UCP3 gene expression
11/02/1999US5976804 The use of these sequences in the diagnosis, treatment, and prevention of cancer, immune disorders, and myopathies.
11/02/1999US5976801 Human reticulocalbin isoforms
11/02/1999US5976800 Enhancement of cancer cell death
11/02/1999US5976787 Possible sites for gene inactivation to attenuate mdv field isolates for vaccine purposes.
11/02/1999US5976785 Competitive assays for determining the effectiveness of a human immunodeficiency virus type 2 (HIV-2) antiviral agent, employing peptides and proteins of HIV-2
11/02/1999US5976597 Basic protein composition, basic peptide composition and application thereof
11/02/1999US5976574 Forming a suspension; spray drying
11/02/1999US5976569 Diketopiperazine-based delivery systems
11/02/1999US5976556 Combination of acid protease enzymes and acidic buffers and uses thereof
11/02/1999US5976551 Altered major histocompatibility complex (MHC) determinant and method of using the determinant
11/02/1999US5976544 Polypeptides and vaccines for Bordetellapertussis and method of use
11/02/1999US5976543 12-kDa protein derived from M. Tuberculosis useful for treatment of autoimmune diseases
11/02/1999US5976541 Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
11/02/1999US5976540 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
11/02/1999US5976539 Compositions and methods for use of IL-12 as an adjuvant
11/02/1999US5976535 Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
11/02/1999US5976534 Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin
11/02/1999US5976533 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
11/02/1999US5976532 Method of antithrombotic therapy using anti-GPIIb/IIIa antibodies or fragments thereof, including c7E3
11/02/1999US5976530 Peptide plasminogen activators
11/02/1999US5976529 Methods of enzyme therapy by orally administering crosslinked enzyme crystals
11/02/1999US5976528 Used to decrease the risk of chemical carcinogenesis comprising administering to a subject in need of such treatment an effective amount.
11/02/1999US5976527 High surface area support having bound latex particles containing oxirane groups for immobilization of substances
11/02/1999US5976524 That produces urine and develops a ureter that facilitates externalization of the urine.
11/02/1999US5976523 Method for healing compromised tissues using pyrimidine derivatives
11/02/1999US5976522 Lymphocyte chemoattractant factor and uses thereof
11/02/1999US5976492 Radioactive phosphorus labeled proteins for targeted radiotherapy
11/02/1999US5976102 Applicator system for two component mixture and suction control
11/02/1999CA2144055C Cloning and sequencing of allergens of dermatophagoides (house dust mite)
11/02/1999CA2119443C Human cyclin e
11/02/1999CA2053911C Recombinant antibody-toxin fusion protein
11/02/1999CA1340813C Bacillus thuringiensis isolate denoted b.t. ps81f active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
11/02/1999CA1340810C Polypeptide derivatives of human granulocyte colony stimulating factor
11/02/1999CA1340809C Process for producing a novel antifungal product from pediococcus sp.
10/1999
10/30/1999CA2269221A1 Active hedgehog protein conjugate, process for its production and use
10/29/1999CA2230203A1 Delta ribozyme for rna cleavage
10/28/1999WO1999054735A1 Improved immunodiagnostic assays using reducing agents
10/28/1999WO1999054707A2 Fetal testing for prediction of low birth weight
10/28/1999WO1999054706A2 Method of treating interstitial cystitis with recombinant hb-egf
10/28/1999WO1999054507A1 Repeat polymorphism in the frataxin gene and uses therefor
10/28/1999WO1999054486A1 Canine erythropoietin gene and recombinant protein
10/28/1999WO1999054485A1 A method for inhibiting tumor invasion or spreading in a subject
10/28/1999WO1999054484A1 Modified immunoglobulin molecules and methods for use thereof
10/28/1999WO1999054482A1 Dna fragmentation factor involved in apoptosis
10/28/1999WO1999054481A1 Mutant having uracil phosphoribosyl transferase activity
10/28/1999WO1999054479A2 INHIBITION OF ALKYL HYDROPEROXIDE REDUCTASE, SUBUNIT C (AhpC) TO IMPART SUSCEPTIBILITY TO ANTIMICROBIAL REACTIVE NITROGEN INTERMEDIATES
10/28/1999WO1999054474A2 Bacterial yiha polypeptide family
10/28/1999WO1999054473A2 Bacterial yjeq polypeptide family
10/28/1999WO1999054470A2 Bacterial ygjd polypeptide family
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054468A1 Soluble protein ztmpo-1
10/28/1999WO1999054465A2 Gene encoding syntaxin interacting protein
10/28/1999WO1999054464A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
10/28/1999WO1999054463A2 Human k+ ion channel and therapeutic applications thereof
10/28/1999WO1999054462A2 Bacterial ycfb polypeptide family
10/28/1999WO1999054461A2 Human nucleic acid sequences of endometrium tumour tissue
10/28/1999WO1999054460A2 Human nucleic acid sequences of normal bladder tissue
10/28/1999WO1999054459A2 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
10/28/1999WO1999054456A1 ANTISENSE OLIGONUCLEOTIDES FOR THE INHIBITION OF INTEGRIN αv-SUBUNIT EXPRESSION
10/28/1999WO1999054450A1 Assay methods for modulators of hematopoietic cell phosphatase
10/28/1999WO1999054449A2 Dyskerine and dyskerine coding dna molecule, vectors containing the same, antibodies against dyskerin and utilization of said elements
10/28/1999WO1999054448A2 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue
10/28/1999WO1999054447A2 Human nucleic acid sequences of bladder tumour tissue
10/28/1999WO1999054446A2 Human nucleic acid sequences which are overexpressed in normal pancreas tissue
10/28/1999WO1999054443A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep
10/28/1999WO1999054442A1 Protein phosphatase methylesterase dna
10/28/1999WO1999054440A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
10/28/1999WO1999054437A2 Novel molecules of the t125-related protein family and uses thereof
10/28/1999WO1999054436A2 Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof
1 ... 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 ... 3163